Related Experiment Video
Updated: Apr 28, 2026

08:50
How to Study Placebo Responses in Motion Sickness with a Rotation Chair Paradigm in Healthy Participants
Published on: December 14, 2014
12.8K
Hahnemann and placebo
1Leiter des Instituts für Geschichte der Medizin der Robert Bosch Stiftung, Straussweg 17, D-70184 Stuttgart, Germany.
Homeopathy : the Journal of the Faculty of Homeopathy
|June 17, 2014
Summary
Samuel Hahnemann, the founder of homeopathy, systematically used placebos, prescribing them in 54-85% of cases. This practice aimed to satisfy patients accustomed to frequent, conventional
Area of Science:
- History of Medicine
- Homeopathy
- Clinical Pharmacology
Background:
- This study examines Samuel Hahnemann's systematic use of placebos, drawing on unpublished documents and his case journals.
- Hahnemann, founder of homeopathy, differentiated between homeopathic remedies and "sham medicine" like milk sugar.
Discussion:
- Hahnemann's case journals indicate a high placebo prescription rate (54-85%), often marked with '§'.
- The practice addressed patient expectations for frequent medication, common during the "heroic medicine" era.
Key Insights:
- Hahnemann's systematic placebo administration was a strategy to manage patient impatience and adherence.
- Placebos were distinct from homeopathic drugs, viewed as a tool to satisfy patients accustomed to allopathic medicine.
Outlook:
- Further research could explore the long-term impact of Hahnemann's placebo practices on patient-physician dynamics.
- Understanding historical placebo use offers insights into contemporary patient-centered care and therapeutic communication.
Related Concept Videos
The Placebo Effect
5.9K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
5.9K
Blind Procedures
10.8K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.8K
Blinding
2.9K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.9K
Classical Conditioning in Daily Life
2.9K
Classical conditioning, a fundamental principle of associative learning, explains various phenomena observed in daily life, such as fear development, the placebo effect, taste aversion, and drug habituation. These applications demonstrate the profound impact of associative learning on human behavior and physiological responses.
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
John B. Watson and Rosalie Rayner famously demonstrated the development of fear through classical conditioning in their experiment with Little Albert. They paired the...
2.9K
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
241
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
241
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K

